Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Letter to the Editor

Letter regarding “Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation”

Yun-Fan Liaw

Clin Mol Hepatol. 2024;30(2):269-271. Published online January 31, 2024

DOI: https://doi.org/10.3350/cmh.2024.0064

View: 663 Download: 21

Editorial

Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen

Chen-Te Huang, Tai-Chung Tseng

Clin Mol Hepatol. 2024;30(2):154-156. Published online February 22, 2024

DOI: https://doi.org/10.3350/cmh.2024.0120

View: 639 Download: 27

Original Article

Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis

Yu Jun Wong, Vy H. Nguyen, Hwai-I Yang, Jie Li, Michael Huan Le, Wan-Jung Wu, Nicole Xinrong Han, Khi Yung Fong, Elizebeth Chen, Connie Wong, Fajuan Rui, Xiaoming Xu, Qi Xue, Xin Yu Hu, Wei Qiang Leow, George Boon-Bee Goh, Ramsey Cheung, Grace Wong, Vincent Wai-Sun Wong, Ming-Whei Yu, Mindie H. Nguyen

Clin Mol Hepatol. 2023;29(3):705-720. Published online May 8, 2023

DOI: https://doi.org/10.3350/cmh.2023.0004

View: 3636 Download: 206 Web of Science: 11 Crossref: 14

Review

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol. 2016;22(4):423-431. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0069

View: 12806 Download: 545 Web of Science: 48 Crossref: 47

Original Article

Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers

Kyun-Hwan Kim, Hye-Young Chang, Jun Yong Park, Eun-Sook Park, Yong Kwang Park, Kwang-Hyub Han, Sang Hoon Ahn

Clin Mol Hepatol. 2014;20(3):251-260. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.251

View: 8682 Download: 77 Web of Science: 7 Crossref: 9

Editorial

Occult hepatitis B virus infection: clearance or disguise?

Jin-Wook Kim

Clin Mol Hepatol. 2014;20(3):249-250. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.249

View: 7081 Download: 54

Review

Risk stratification of HBV infection in Asia-Pacific region

Jia-Horng Kao

Clin Mol Hepatol. 2014;20(3):223-227. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.223

View: 8724 Download: 85 Web of Science: 19 Crossref: 17

Original Article

Inactıve hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study

Nese Demirturk, Tuna Demirdal

Clin Mol Hepatol. 2014;20(1):56-60. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.56

View: 8006 Download: 56 Web of Science: 2 Crossref: 1

HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data

Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2013;19(4):409-416. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.409

View: 6129 Download: 61 Crossref: 6

Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B

Joon Chang Song, Bo Young Min, Jin-Wook Kim, Jong Yeop Kim, Yeo Myeong Kim, Cheol Min Shin, Sang Hyub Lee, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee

Clin Mol Hepatol. 2011;17(4):268-273. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.268

View: 7385 Download: 63 Crossref: 8

3

The relationship between hepatitis B virus infection and the incidence of pancreatic cancer: a retrospective case-control study

Seung Goun Hong, M.D., Ji Hoon Kim, M.D., Young Sun Lee, M.D., Eileen Yoon, M.D., Hyun Jung Lee, M.D., Jin Ki Hwang, M.D., Eun Suk Jung, M.D., Moon Kyung Joo, M.D., Young Kul Jung, M.D., Jong Eun Yeon, M.D., Jong-Jae Park, M.D., Jae Seon Kim, M.D., Young-Tae Bak, M.D., Kwan Soo Byun, M.D.

Clin Mol Hepatol. 2010;16(1):49-56. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.49

View: 5095 Download: 87 Crossref: 13

Current status of Liver diseases in Korea: Hepatitis B

Hee Bok Chae , Jong Hyun Kim , Ja Kyung Kim , Hyung Joon Yim

Clin Mol Hepatol. 2009;15(60):13-24. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S13

View: 8105 Download: 96 Crossref: 75

7

The Korean Journal Of Clinical outcomes and development of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients

Ji Hoon Kim

Clin Mol Hepatol. 2009;15(3):383-390. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.383

View: 3647 Download: 15

4

Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic Lymphocytic Leukemia

Suang Min Lim , Jeong Won Jang , Byung Wook Kim , Hwang Choi , Kyu Yong Choi , Soo Jeong Park , Chi Wha Han

Clin Mol Hepatol. 2008;14(2):213-218. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.213

View: 4551 Download: 46 Crossref: 6

3

Serologic Markers of Hepatitis B Virus in Pregnant Women in Jeju Island

Hyun Sung Kang, M.D. , Byung-Cheol Song, M.D., Cui Xiu Ji, M.D., Sung-Yob Kim, M.D.* and Suk Kyun Kim, M.D.

Clin Mol Hepatol. 2004;10(3):191-196. Published online January 1, 2000

View: 2676 Download: 25

Serum ALT and HBV DNA Levels in Patients with HBeAg-Negative Chronic Hepatitis B

Kyung Hwan Kim, M.D., Il Hwan Na, M.D., Jae Moon Cha, M.D., Yong Ki Cho, M.D., Se Young Park, M.D., Hyoung Pil Kim, M.D., Chul Soo Song, M.D., Jeong Heo, M.D. and Mong Cho, M.D.

Clin Mol Hepatol. 2003;9(4):284-292. Published online January 1, 2000

View: 2992 Download: 29

The Correlation Between The Histologic Activity and Fibrosis and The Distribution of Intrahepatic HBsAg and HBcAg in Patients With Chronic Hepatitis B

Kwang Bum Cho, M.D., Jung Ho Sohn, M.D., Kyung Sik Park, M.D., Du Young Kwon, M.D., Jae Seok Hwang, M.D., Jung Wook Hur, M.D., Sung Hoon Ahn, M.D., Soong Kuk Park, M.D., and Sang Pyo Kim, M.D.*

Clin Mol Hepatol. 2001;7(4):401-412. Published online January 1, 1970

View: 2190 Download: 17

Changes in the Positivities of HBsAg and Anti-HCV Antibody among Army Draftees in Korea

Rock Kwon Kim, M.D., Byung Min Ahn M.D., Dong Soo Lee , M.D., Kang Moon Lee M.D., Young Min Park M.D., Young Sok Lee , M.D., Kyu Won Chung , M.D., Won Chul Lee , M.D., and Kwang Ho Meng , M.D.

Clin Mol Hepatol. 2000;6(4):474-480. Published online January 1, 2000

View: 2310 Download: 16

Persistent Negative Anti-HBc in Chronic Hepatitis B Virus Carrier -Clinical Review, HBcAg and Nucleotide Sequence of It`s Epitope in HLA A2 Heterozygotes-

Jae Heung Kim,Haak Cheoul Kim

Clin Mol Hepatol. 1999;5(2):105-115. Published online January 1, 2000

View: 2258 Download: 15

1 |

Viewed By 5139	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5001	MAFLD: How is it different from NAFLD?
Viewed By 4902	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3634	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3576	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search